Abstract
Alnylam has reported the first use in humans of a small interfering RNA (siRNA) to reduce levels of LDL cholesterol (LDL-C). The siRNA, inclisiran, is......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
